Yahoo!: Analysts' Upgrades, Downgrades

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Abbott Laboratories ( ABT) downgraded at RBC from Top Pick to Outperform, RBC Capital said. Estimates also cut, following new healthcare reform rules. $60 price target.

Arch Coal ( ACI) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Valuation call.

Ansys ( ANSS) downgraded at Oppenheimer to Perform, Oppenheimer said. Valuation call, based on a $51 price target.

Baxter International ( BAX) upgraded at RBC from Outperform to Top Pick, RBC Capital said. $57 price target. Company is cutting costs and has potential operating leverage in the new year.

Baxter International ( BAX) initiated at Barclays with an Equal Weight rating and $56 price target. Pricing and competition will impede top-line growth and profitability in 2011 & 2012, Barclays said.

BHP Billiton ( BHP) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. Valuation call.

Centene ( CNC) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Company could be hurt by lower state Medicaid reimbursement.

Cinemark ( CNK) upgraded at Morgan Stanley to Equal-weight, Morgan Stanley said. Company continues to grow in Latin America. $20 price target.

Convergys ( CVG) upgraded at Baird from Neutral to Outperform, Robert Baird said. $17 price target. Industry trends are beginning to improve.

Dangdang ( DANG) rated new Neutral at Jefferies. $30 price target. Company is a market leader in the Chinese retail market, which can grow nearly 50% annually.

EMC ( EMC) upgraded at BMO from Market Perform to Outperform, BMO Capital said. $30 price target. Company is gaining market share.

First Republic ( FRC) rated new Hold at Jefferies. $31 price target. Company can generate double-digit organic earnings growth.

GenOn Energy ( GEN) upgraded at Citigroup from Hold to Buy, Citigroup said. $5.25 price target. Potential negative regulatory headlines from NJ have passed.

Hospira ( HSP) initiated at Barclays with an Overweight rating and $66 price target. Multiple drug and device opportunities should provide upside to estimates and support long-term EPS growth, Barclays said.

Humana ( HUM) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Company will likely be hurt by Medicare Advantage cuts.

Janus Capital ( JNS) downgraded at Citigroup from Hold to Sell, Citigroup said. Valuation call, based on a $12 price target.

SemiLEDS ( LEDS) initiated at Barclays with an Equal Weight rating and $20 price target. LEDS is an emerging high brightness LED supplier offering quality and cost leadership, Barclays said. 2011 and 2012 EPS estimates set at $0.70 and $0.91, respectively.

McDonald's ( MCD) upgraded at RBC from Sector Perform to Outperform, RBC Capital said. Valuation call, as the company is a good inflation play. $85 price target.

Mohawk Industries ( MHK) downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call, as the company lacks near-term catalysts.

Molex ( MOLX) upgraded at JP Morgan from Underweight to Overweight, JP Morgan said. Company has exposure to mobile devices and networking.

Nvidia ( NVDA) downgraded at BMO from Outperform to Market Perform, BMO Capital said. Valuation call, based on a $22 price target.

Patriot Coal ( PCX) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Company has leverage to higher met coal prices.

Symantec ( SYMC) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $22 price target. Company can generate better sales growth in the new year.

Sysco ( SYY) downgraded at BB&T from Buy to Hold, BB&T Capital said. Company is facing flat near-term earnings growth.

Ultimate Software ( ULTI) downgraded at Morgan Keegan from Outperform to Market Perform, Morgan Keegan said. $55 price target. Stock is already pricing in potential takeover speculation.

Virgin Media ( VMED) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, as the stock gained more than 60% in 2010.

Yahoo! ( YHOO) downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Estimates also cut, as fundamentals are deteriorating. $19 price target.

Youku.com ( YOKU) rated new Neutral at Piper Jaffray. Valuation call, based on a $40 price target.

This article was written by a staff member of TheStreet.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says